Investigator Dr. Maryam Oskoui Receives CIHR Grant to Fund Spinal Muscular Atrophy Clinical Trial

NMD4C investigator Dr. Maryam Oskoui has been awarded a Canadian Institutes of Health Research Clinical Trials Operating Grant ($1,777,095) for INFORM SMA as nominated principal applicant. Several NMD4C members are listed on this grant as co-investigators, including Katrina Cardiff, Shaainthabie Karthigesu, Dr. Kathryn Selby, Dr. Jean Mah, Dr. Heran Gonorazky, Dr. Hugh McMillan, Dr. Jordan Sheriko, Dr. Victoria Hodgkinson, and Dr. Lawrence Korngut; and as collaborators, including Niamh Cushen, Catherine Desautels, Dr. James Dowling, Monique Emond, Stacey Lintern, Sarah Turgeon-Desilets, Susi Vander Wyk, and Angelina Woof.

INFORM SMA

INFORM SMA is embedded in the INFORM RARE network, whose vision is to improve health care for children with rare genetic diseases by generating real-world evidence to support decision-making about new and existing therapies. The goal of this trial is to evaluate the effectiveness of a home-based exergame intervention in promoting physical activity for children and youth with Spinal muscular atrophy (SMA) while validating digital outcome measures. Multiple knowledge users (patients, parents, healthcare providers, and researchers) have informed the design of both the exergame intervention and the trial. This registry-based trial will also identify the best tools to measure meaningful change in this population and provide the framework for future pragmatic trials in SMA.

CIHR recently featured Dr. Oskoui’s innovative trial in their “Faces of Health Research” initiative. Read the full feature to learn more!

Links

1. https://cihr-irsc.gc.ca/e/53357.html?filter=Maryam+Oskoui
2. https://www.informrare.ca/

Oskoui clinical trial graphic_4x3

Read next...

poster congratulating King's Medal Recipient

King’s Medal Awarded to Canadian Neuromuscular Clinicans and Researchers

Several NMD4C investigators and collaborators from the Canadian neuromuscular community have been awarded a King Charles III’s Coronation Medal in recognition of their outstanding contributions and service.

Announcement poster reading: New home online for NMD4C community of practice

New Home on NMD4C Website for Community of Practice

Check out the new home for the NMD4C community of practice (CoP), now live on the NMD4C website!

announcement text reading: New NMD4C Collaborative Research Training Awards, launching May 7 2025

New NMD4C Collaborative Research Training Awards Launching May 2025

The NMD4C is excited to announce a new program for neuromuscular research trainees that will support collaboration opportunities between Canadian research labs.

Neuromuscular research funding opportunities

Neuromuscular Research Grant Competitions from Defeat Duchenne Canada and Myotonic Dystrophy Foundation You Can Apply For Today!

Applications are open for Defeat Duchenne Canada’s research grant cycle, and Myotonic Dystrophy Canada’s fellowship and scholar grant programs.

NMD4C Reaches 800-Member Milestone!

NMD4C Reaches 800 Member Milestone

We are thrilled to announce that the NMD4C has reached the milestone of 800 members! This incredible number shows the strength and engagement of the diverse neuromuscular community in Canada.

Text reading NMD4C joins bluesky - We're now active on Bluesky! We invite you to follow us at @nmd4c.ca to stay updated on news from our Canadian neuromuscular network. NMD4C and bluesky logo, with an image of the NMD4C bluesky feed.

You Can Now Find NMD4C on Bluesky

We’re moving to Bluesky! The NMD4C will now share updates on Bluesky instead of X. Please consider following us at @nmd4c.ca to stay connected!